Skip to main content
Premium Trial:

Request an Annual Quote

PacBio, Bluebee Partner to Develop De Novo Assembly Pipeline

NEW YORK (GenomeWeb) – Pacific Biosciences and genomics analysis company Bluebee have partnered to develop a de novo assembly pipeline that combines the firm's respective technologies.

They plan to integrate PacBio's de novo assembly pipeline for its single-molecule sequencing platform and Bluebee's cloud-based analysis platform. Netherlands-based Bluebee offers a private, cloud-based genomics analysis platform, designed to work with confidential sample information, meeting security and regulatory standards in the US, the UK, Europe, and Canada.

"The end-to-end solution integrates downstream data analysis in Bluebee's high-security and regulatory-compliant compute centers for PacBio customers around the world," Kevin Corcoran, senior vice president of market development for PacBio, said in a statement.

The solution will be customizable — users can adjust parameters within the platform and optimize it for their specific use cases. Bluebee CEO Hans Cobben further noted that the solution will "address the data analysis burden" of many users.

The Scan

Comfort of Home

The Guardian reports that AstraZeneca is to run more clinical trials from people's homes with the aim of increasing participant diversity.

Keep Under Control

Genetic technologies are among the tools suggested to manage invasive species and feral animals in Australia, Newsweek says.

Just Make It

The New York Times writes that there is increased interest in applying gene synthesis to even more applications.

Nucleic Acids Research Papers on OncoDB, mBodyMap, Genomicus

In Nucleic Acids Research this week: database to analyze large cancer datasets, human body microbe database, and more.